US Patent 9428534 Antisense design

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

March 12, 2013

Date of Patent

August 30, 2016

Patent Application Number

13797913

Patent Citations Received

‌

US Patent 11891605 Reducing intron retention

‌

US Patent 11911484 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

‌

US Patent 11931421 Muscle targeting complexes and formulations for treating myotonic dystrophy

‌

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

‌

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

‌

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

‌

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

‌

US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

‌

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

‌

US Patent 11873490 Antisense oligomers for treatment of conditions and diseases

Patent Inventor Names

Miriam Frieden

Charlotte Albaek Thrue

Christoph Rosenbohm

Daniel Sejer Pedersen

Henrik Frydenlund Hansen

Majken Westergaard

Nikolaj Dam Mikkelsen

Signe M. Christensen

Troels Koch

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9428534

Patent Primary Examiner

‌

Tracy Vivlemore

Find more entities like US Patent 9428534 Antisense design

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API